umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.ORCID-id: 0000-0002-2974-2003
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Patologi.
Umeå universitet, Samhällsvetenskapliga fakulteten, Handelshögskolan vid Umeå universitet, Statistik.ORCID-id: 0000-0002-9086-7403
Umeå universitet, Medicinska fakulteten, Enheten för biobanksforskning. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden..ORCID-id: 0000-0001-6808-4405
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: International Journal of Cancer, ISSN 0020-7136, E-ISSN 1097-0215, Vol. 145, nr 2, s. 327-337Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Factors related to energy metabolism and the metabolic syndrome, such as higher body mass index (BMI), blood glucose, or blood lipids, and blood pressure, are associated with an increased risk of colorectal cancer (CRC). However, CRC is a heterogeneous disease, developing through distinct pathways with differences in molecular characteristics and prognosis, and possibly also in risk factors. For subtypes defined by KRAS and BRAF mutation status, BMI is the only metabolic factor previously studied, with inconsistent findings. We investigated whether associations between BMI, blood glucose, blood lipids, and blood pressure and CRC risk differed by tumor KRAS and BRAF mutation status in 117,687 participants from two population-based cohorts within the Northern Sweden Health and Disease Study (NSHDS). Hazard ratios (HRs) for overall CRC and CRC subtypes by metabolic factors were estimated with Cox proportional hazards regression, using multiple imputation to handle missing exposure and tumor data. During a median follow-up of 15.6 years, we acquired 1,250 prospective CRC cases, of which 766 cases had complete baseline and molecular tumor data. Consistent with previous evidence, higher BMI, total cholesterol, triglyceride levels, and blood pressure were associated with an increased risk of overall CRC (HRs per 1 standard deviation increase: 1.07 to 1.12). These associations were similar regardless of CRC subtype by KRAS and BRAF mutation status (all pheterogeneity > 0.05). The same was true for subtypes based on microsatellite instability status. Poor metabolic health may therefore be a universal mechanism for colorectal cancer, acting across multiple developmental pathways.

Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2019. Vol. 145, nr 2, s. 327-337
Nyckelord [en]
BRAF, KRAS, colorectal cancer, metabolic factors, microsatellite instability, risk factors
Nationell ämneskategori
Cancer och onkologi Näringslära
Identifikatorer
URN: urn:nbn:se:umu:diva-158782DOI: 10.1002/ijc.32104PubMedID: 30613980Scopus ID: 2-s2.0-85060622510OAI: oai:DiVA.org:umu-158782DiVA, id: diva2:1314324
Anmärkning

Originally included in thesis in manuscript form with title [Metabolic factors and colorectal cancer risk by KRAS and BRAF mutation status]

Tillgänglig från: 2019-05-08 Skapad: 2019-05-08 Senast uppdaterad: 2019-06-11Bibliografiskt granskad
Ingår i avhandling
1. Metabolic Risk Factors and Molecular Subtypes of Colorectal Cancer
Öppna denna publikation i ny flik eller fönster >>Metabolic Risk Factors and Molecular Subtypes of Colorectal Cancer
2018 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Alternativ titel[sv]
Metabola Riskfaktorer och Molekylära Subtyper av Kolorektalcancer
Abstract [en]

Background: Colorectal cancer (CRC) is a heterogeneous disease developing from distinct pathways, resulting in tumor subtypes with large differences in clinical and molecular characteristics. Molecular characteristics are increasingly being used clinically to guide therapy. However, whether molecular subtypes of CRC differ in etiology or risk factors is not clear. Clarifying such potential differences may lead to an improved understanding of CRC etiology, with implications for CRC prevention and screening.

Aim: The aim of this thesis was to investigate whether risk factors related to energy metabolism, such as body fatness, and one-carbon metabolism, such as circulating B-vitamin status, were associated with specific subtypes of CRC defined by molecular characteristics of the tumor. 

Methods: These prospective studies are based on data and blood samples from cohorts within the population-based Northern Sweden Health and Disease Study (NSHDS). Prospective CRC cases with available archived tumor tissue were analyzed for key molecular features (KRAS and BRAF mutation status, Microsatellite instability (MSI) status, and CpG Island Methylator Phenotype (CIMP) status). Paper I was a cohort study of metabolic factors related to the metabolic syndrome (117 687 participants). Paper II was a nested-case control study on circulating insulin resistance-markers and adipokines (1010 cases and 1010 matched controls). Papers III and IV were nested case-control studies of one-carbon metabolism biomarkers and genetic variants (613 cases and 1190 matched controls).

Results: In paper I, we observed associations between metabolic factors, such as BMI, blood pressure, and blood lipids, and CRC risk consistent with previous studies. These associations were similar regardless of tumor KRAS and BRAF mutation status. In paper II, circulating biomarkers of insulin resistance and adipokines were not associated with the risk of CRC or specific molecular subtypes of CRC defined by KRAS and BRAF mutation or MSI status. In paper III, higher circulating levels of metabolites involved in the methionine cycle (namely, betaine and methionine) were associated with a lower CRC risk. In paper IV, we found no support for clear subtype-specific roles of any circulating one-carbon metabolism biomarker or genetic variants in CRC development.

Conclusions: The result of these prospective studies suggests that metabolic factors related to energy metabolism and one-carbon metabolism are generally associated with the risk of CRC, regardless of major subtypes defined by key molecular tumor features. If causal, metabolic risk factors likely influence the risk of colorectal cancer through more than one carcinogenic pathway.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå Universitet, 2018. s. 70
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 1975
Nyckelord
Colorectal cancer, risk factors, metabolic syndrome, one-carbon metabolism, molecular subtypes, KRAS, BRAF, MSI, molecular pathological epidemiology
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
cancerepidemiologi
Identifikatorer
urn:nbn:se:umu:diva-151753 (URN)978-91-7601-939-9 (ISBN)
Disputation
2018-10-12, Sal 260, Norrlands Universitetssjukhus, Målpunkt A21, Byggnad 3A, vån 2., Umeå, 09:00 (Engelska)
Opponent
Handledare
Tillgänglig från: 2018-09-21 Skapad: 2018-09-12 Senast uppdaterad: 2019-05-15Bibliografiskt granskad

Open Access i DiVA

fulltext(1337 kB)48 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 1337 kBChecksumma SHA-512
2efa150fe85481c594c6be7f888535b150eb39247924babdd18143046b476c943de4cf7264ca619d68978deab138ec3f06b5cbfd177b9eafd4d767b9c6a2e7c0
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Personposter BETA

Myte, RobinGylling, BjörnHäggström, JennyHäggström, ChristelZingmark, CarlLöfgren Burström, AnnaPalmqvist, Richardvan Guelpen, Bethany

Sök vidare i DiVA

Av författaren/redaktören
Myte, RobinGylling, BjörnHäggström, JennyHäggström, ChristelZingmark, CarlLöfgren Burström, AnnaPalmqvist, Richardvan Guelpen, Bethany
Av organisationen
OnkologiPatologiStatistikEnheten för biobanksforskningWallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
I samma tidskrift
International Journal of Cancer
Cancer och onkologiNäringslära

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 60 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 281 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf